BioCentury
ARTICLE | Company News

Alexza, Teva deal

November 23, 2015 8:00 AM UTC

Alexza will regain U.S. rights to Adasuve loxapine from Teva, effective Jan. 1, 2016. Alexza, which granted Teva U.S rights in 2013, said it plans to identify a new U.S. commercial partner for the pr...